|
|
| Article |
Antigens evaluated |
|
CD2 is expressed by a subpopulation of normal B cells and is frequently
present in mature B-cell neoplasms. |
CD2 |
|
Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin
lymphomas. |
CD2, CD4, CD7, CD8 |
|
CD5+ follicle center lymphoma. Immunophenotyping detects a unique subset
of "floral" follicular lymphoma. |
CD5, CD10, t(14;18) |
|
B-cell lymphomas with coexpression of CD5 and CD10 |
CD5, CD10, Bcl-1, Bcl-6, CD43, t(11;14) |
|
Low-grade B-cell
lymphoma with coexpression of both CD5 and CD10. A report of 3 cases. |
CD5, CD10 |
|
CD5+ follicular lymphoma: a clinicopathologic study of three cases. |
CD5, CD10, Bcl-2, Bcl-6, Bcl-1, CD43, IgD, t(14;18) |
|
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. |
CD5, CD10, CD19, CD20, CD21, Bcl-6 |
|
Assessment of CD10 in the diagnosis of small B-cell lymphomas: a
multiparameter flow cytometric study. |
CD5, CD10, Bcl-1 |
|
Paraffin immunoreactivity of CD10, CDw75, and Bcl-6 in follicle center
cell lymphoma. |
CD10, Bcl-2, Bcl-6, CDw75 |
|
CD10-MUM1+ follicular
lymphoma lacks BCL2 gene translocation and
shows characteristic biologic and clinical
features. |
CD10, Mum-1, Bcl-2, Bcl-6 |
|
Aberrant expression and
reverse signalling of CD70 on malignant B cells. |
CD27, CD40, CD70 |
|
